MacroGenics | MGNX - Loan Capital


MacroGenics reported $68.71M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Amgen USD 51.89B 1.88B Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
Biogen USD 6.29B 1.7M Mar/2026
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
Daiichi Sankyo JPY 300.15B 199.41B Dec/2025
Eli Lilly USD 39.37B 1.5B Mar/2026
Genmab DKK 5.14B 5.01B Dec/2025
Geron USD 119.83M 286K Mar/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
J&J USD 37.34B 183M Jun/2026
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025
MacroGenics USD 68.71M 1.29M Mar/2026
Merck USD 46.67B 77M Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
Puma Biotechnology USD 10.87M 222K Jun/2025
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Xencor USD 82.12M 5.64M Mar/2026